Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: i


Summaries of Product Characteristics 1 - 30 of 191
  1  2  3  4  5  6  7  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Iasibon - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Ibandronat Stada 150 mg tabletti, kalvopäällysteinen SPC 2021-11-16

PL

Resepti

Ibandronate ratiopharm 150 mg tabletti, kalvopäällysteinen SPC 2021-02-10

PL

Resepti

Ibandronate ratiopharm 50 mg tabletti, kalvopäällysteinen SPC 2021-02-10

European Medicines Agency's website:
Ibandronic acid Accord - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Ibandronic Acid Sandoz - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Ibandronic Acid Teva - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Ibrance - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Ibrance - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Ibumax 200 mg, 400 mg tabletti, kalvopäällysteinen SPC 2021-12-09 OTC

PL

Resepti

Ibumax 200 mg, 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2021-12-09

PL

Itsehoito

Ibumax-C 400 mg-300mg tabletti, kalvopäällysteinen SPC 2021-12-03

PL

Resepti

Ibumetin 600 mg tabletti, kalvopäällysteinen SPC 2021-09-01

PL

Resepti

Ibuprofen Accord 400 mg tabletti, kalvopäällysteinen SPC 2022-06-28

PL

Resepti

Ibuprofen Accord 600 mg tabletti, kalvopäällysteinen SPC 2022-06-28

PL

Resepti

Ibuprofen B. Braun 200 mg infuusioneste, liuos SPC 2021-07-08

PL

Resepti

Ibuprofen B. Braun 400 mg infuusioneste, liuos SPC 2021-12-28

PL

Resepti

Ibuprofen B. Braun 600 mg infuusioneste, liuos SPC 2021-12-28

PL

Resepti/itsehoito

Ibuprofen Farmalider 20 mg - ml, 40 mg - ml oraalisuspensio SPC 2021-01-20

PL

Resepti

Ibuprofen Zentiva 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2021-07-12.docx

PL

Itsehoito

Ibusal 200 mg, 400 mg tabletti, kalvopäällysteinen SPC 2020-12-18 OTC

PL

Resepti

Ibusal 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2020-12-18

PL

Itsehoito

Ibutabs 400 mg tabletti, kalvopäällysteinen SPC 2020-12-18

PL

Resepti/itsehoito

Ibuver 400 mg tabletti, kalvopäällysteinen SPC 2020-12-28

PL

Resepti/itsehoito

Ibuxin 20 mg - ml, 40 mg - ml siirappi SPC 2020-12-22

PL

Itsehoito

Ibuxin 400 mg jauhe SPC 2021-07-07

PL

Itsehoito

Ibuxin 400 mg tabletti, kalvopäällysteinen SPC 2020-08-20 OTC

PL

Resepti

Ibuxin 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2020-08-20

PL

Resepti/itsehoito

Ibuxin rapid 400 mg tabletti kalvopäällysteinen SPC 2021-02-02

European Medicines Agency's website:
Icandra (ent. Vildagliptin/Metformin Hydrochloride Novartis) - EMA: EPAR PI
Finnish Swedish

  1  2  3  4  5  6  7  |  Next 30   >